Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
US8277806B2 · kind B2 · utility
14Cited by
7References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 3, 2003 |
| Grant date | Oct 2, 2012 |
| Priority date | — |
| Expiry date | Aug 11, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/31
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention describes the use of a pharmaceutical preparation containing a trifunctional bispecific and/or trispecific having the following properties:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.